Amyloidosis, especially wild-type transthyretin (TTR) amyloidosis, is underdiagnosed in older people, for whom “red flags” may be misread [147] and prognosis may be affected by diagnostic delays, despite available treatments [148]. The gene discussed is TTR; the disease is amyloidosis.